625
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Gold nanoprobe-based method for sensing activated leukocyte cell adhesion molecule (ALCAM) gene expression, as a breast cancer biomarker

, , &
Pages 277-282 | Received 26 Nov 2015, Accepted 21 Jan 2016, Published online: 28 Feb 2016

References

  • Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2016. Graphene: Synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 44:150–156.
  • Baptista PV, Koziol-Montewka M, Paluch-Oles J, Doria G, Franco R. 2006. Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem. 52:1433–1434.
  • Bergen JM, von Recum HA, Goodman TT, Massey AP, Pun SH. 2006. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci. 6:506–516.
  • Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. 2006. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 22:577–583.
  • Chen Z, Wang Z, Chen X, Xu H, Liu J. 2013. Chitosan-capped gold nanoparticles for selective and colorimetric sensing of heparin. J Nanopart Res. 15:1–9.
  • Conde J, de la Fuente JM, Baptista PV. 2010. RNA quantification using gold nanoprobes - application to cancer diagnostics. J Nanobiotechnol. 8:5.
  • Daraee H, Pourhassanmoghadam M, Akbarzadeh A, Zarghami N, Rahmati-Yamchi M. 2015. Gold nanoparticle–oligonucleotide conjugate to detect the sequence of lung cancer biomarker. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1031905.
  • DeSantis C, Ma J, Bryan L, Jemal A. 2014. Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62.
  • Ding Y, Jiang Z, Saha K, Kim CS, Kim ST, Landis RF, Rotello VM. 2014. Gold nanoparticles for nucleic acid delivery. Mol Ther. 22:1075–1083.
  • Doria G, Franco R, Baptista P. 2007. Nanodiagnostics: fast colorimetric method for single nucleotide polymorphism/mutation detection. IET Nanobiotechnol. 1:53–57.
  • Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A. 2016. Nanofiber: Synthesis and biomedical applications. Artif Cells Nanomed Biotechnol 44:111–121.
  • Fallahzadeh S, Bahrami H, Akbarzadeh A, Tayarani M. 2010. High-Isolation Dual-Frequency Operation Patch Antenna Using Spiral Defected Microstrip Structure. IEEE Antenn Wireless Propag Lett 9:122–124.
  • Farokhzad OC, Langer R. 2009. Impact of nanotechnology on drug delivery. ACS Nano. 3:16–20.
  • Ihnen M, Kohler N, Kerstenc JF, Milde-Langoscha K, Becka K, Holler S, et al. 2010. Expression levels of activated leukocyte cell adhesion molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. Dis Markers. 28:71–78.
  • Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, et al. 2012. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma. J Thorac Oncol. 7:890–899.
  • Jezierska A, Wojciech M, Tomasz M. 2006. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Monitor Basic Res. 12: BR263–BR273.
  • Lee J, Chatterjee DK, Lee MH, Krishnan S. 2014. Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Lett. 347:46–53.
  • Lee B, Kate YJ, Wang Y, Nie S. 2015. In vitro study of a pH-sensitive multifunctional doxorubicin–gold nanoparticle system: therapeutic effect and surface enhanced Raman scattering. RSC Adv. 5:65651–65659.
  • Liu G, Ren H, Guan Y, Dai R, Chai C. 2014. Development of a mercury detection kit based on melamine-functionalized gold nanoparticles. Anal Sci Scis. 31:113–118.
  • Mishra A, Verma M. 2010. Cancer biomarkers: are we ready for the prime time? Cancers. 2:190–208.
  • Nelson EM, Rothberg LJ. 2011. Kinetics and mechanism of single-stranded DNA adsorption onto citrate-stabilized gold nanoparticles in colloidal solution. Langmuir. 27:1770–1777.
  • Piao D, Jiang T, Liu G, Wang B, Xu J, Zhu A. 2012. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Mol Biol Rep. 39:661–668.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A. 2014a. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. Micro Nano Lett. 9.5:345–350.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Daraee H, de la Guardia M, Ahmadian S. 2014b. Gold nanoprobe based label-free detection of human telomerase reverse transcriptase (hTERT) gene expression: gold nanoprobe-based detection of hTERT gene expression. IEEE Trans Nanobiosci. [Epub ahead of print]. doi: 10.1109/TNB.2014.2365256.
  • Swierczewska M, Liu G, Lee S, Chen X. 2012. High-sensitivity nanosensors for biomarker detection. Chem Soc Rev. 41:2641–2655.
  • Witzel I, Schroder C, Muller V, Zander H, Tachezy M, Ihnen M, et al. 2012. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis. Oncology. 82:305–312.
  • Zdrojewicz Z, Waracki M, Bugaj B, Pypno D, Cabała K. 2015. Medical applications of nanotechnology. PostȩPy Hig Med Dośw (Online). 69:1196.
  • Zhou P, Du LF, Lv GQ, Yu XM, Gu YL, Li JP, Zhang C. 2011. Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population. Breast Cancer Res Treat. 128:527–534.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.